A team of MUSC Hollings Cancer Center researchers has discovered one way in which triple-negative breast cancer (TNBC) cells become resistant to immunotherapy and have tested a two-pronged treatment strategy that was able ...
Sep 9, 2024
0
66
Among progressive neurodegenerative diseases, Alzheimer's is one of the most common and most heartbreaking. It robs individuals of their memories and self-sufficiency and can even alter their personalities.
Sep 5, 2024
0
31
People with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to a new analysis by Johns ...
Sep 8, 2024
0
0
An international team of researchers led by Francesca Finotello from the Digital Science Center (DiSC) and the Department of Molecular Biology has derived a molecular signature from tumor transcriptomics data that quantifies ...
Sep 10, 2024
0
1
